tirzepatide fda announcement May 18, 2026: warns 503B compounding pharmacy for producing after shortage ended – Partnership for Safe Medicines Journal Club - 'Twincretin' Tirzepatide

Seamless and lost 20lbs in first month

Your pharmacy sends a 20mg/ml vial this month

Market Competition Effects Compounding Market Dynamics: 2022 (Limited Competition): Few providers High prices ($599-$899/month) Significant barriers to entry 2023-2024 (Expanding Competition): More providers entered Prices declined ($399-$699/month) Technology platforms launched 2025-2026 (Mature Competition): Numerous providers Price competition fierce Prices stabilized ($349-$699/month) Quality differentiation emerging Competitive market drives prices toward efficient levels while maintaining quality

Single-pathway therapies may persist in specific niches where their particular advantages outweigh the benefits of increased complexity, but their role as first-line treatments appears increasingly challenged

Looking at real tirzepatide results from others at similar starting points can help calibrate expectations